Does a Mobile ECLS Program Reduce Mortality for Patients Transported for ECLS Therapy for Severe Acute Respiratory Failure?

Jacob T. Gutsche*, Todd A. Miano, William Vernick, Jesse Raiten, Christian Bermudez, Prashant Vallabjoysula, Karianna Milewski, Wilson Szeto, Meghan Lane Fall, Matthew L. Williams, Prakash Patel, Mark E. Mikkelsen, Cornel Chiu, Harish Ramakrishna, Jeremy Canon, John G. Augoustides

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Objective: To understand if mobile extracorporeal membrane oxygenation reduces patient mortality during and after transport of patients requiring extracorporeal membrane oxygenation for acute respiratory distress syndrome. Design: Retrospective chart review. Setting: University affiliated tertiary care hospitals. Participants: Seventy-seven patients. Interventions: Introduction of a mobile extracorporeal membrane oxygenation (ECMO) program designed to facilitate the implementation of ECMO at outside hospitals in patients too unstable for transport for ECMO. Measurements and Main Results: The 28-day in-hospital mortality was significantly lower in the post-mobile group (12/51 [23.5%] v 12/24 [50%], adjusted risk difference: 28.6%, [95% CI 4.7-52.5, p = 0.011]). Conclusions: These findings suggest that patients with severe acute respiratory failure who require transport to a referral center for extracorporeal life support may benefit from the availability of a mobile extracorporeal life support team.

Original languageEnglish
Pages (from-to)1137-1141
Number of pages5
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume32
Issue number3
DOIs
StatePublished - Jun 2018
Externally publishedYes

Keywords

  • ARDS
  • ECLS
  • ECMO
  • acute respiratory distress syndrome
  • extracorporeal life support
  • extracorporeal membrane oxygenation
  • mobile ECMO
  • mobile life support
  • transport

Fingerprint

Dive into the research topics of 'Does a Mobile ECLS Program Reduce Mortality for Patients Transported for ECLS Therapy for Severe Acute Respiratory Failure?'. Together they form a unique fingerprint.

Cite this